BK Technologies expects FY26 GAAP EPS above $3.15 vs estimate
BK Technologies (AMEX: BKTI) projects FY26 GAAP EPS to exceed $3.15, beating the $3.06 estimate. This complements its prior adjusted EPS outlook of over $3.55 and reaffirmed sales guidance of $90.000 million.

*this image is generated using AI for illustrative purposes only.
BK Technologies (AMEX: BKTI) has updated its fiscal year 2026 earnings outlook with specific guidance on GAAP earnings per share. The communications technology firm now expects its FY26 GAAP EPS to be more than $3.15, surpassing the analyst estimate of $3.06.
This new disclosure supplements the company’s earlier reaffirmation of its adjusted EPS and sales guidance. BK Technologies had previously stated that its FY26 adjusted EPS would beat the estimate of $3.55, while maintaining its sales target at $90.000 million.
Financial Outlook
The following table consolidates the company’s full set of FY26 guidance metrics against market expectations.
| Metric | BK Technologies Estimate | Market Consensus |
|---|---|---|
| Adjusted EPS | > $3.55 | $3.55 |
| GAAP EPS | > $3.15 | $3.06 |
| Sales Guidance | $90.000 million | $90.193 million |
What the Numbers Show
The addition of the GAAP EPS guidance provides a clearer picture of the company’s expected profitability before non-GAAP adjustments. With both adjusted and GAAP EPS projected to exceed their respective consensus estimates, BK Technologies signals confidence in its underlying earnings power for FY26. The divergence between the affirmed sales guidance ($90.000 million) and the higher market consensus ($90.193 million) remains, suggesting continued caution on revenue recognition despite strong earnings expectations.
What specific operational efficiencies or cost-saving measures are driving the GAAP EPS upside despite a sales target slightly below market consensus?
How might the divergence between BK Technologies' conservative revenue guidance and higher market expectations impact investor sentiment and stock volatility in the near term?
Are there any upcoming product launches or contract renewals in FY26 that could justify the company's confidence in beating adjusted EPS estimates?

























